Clinical Advances in Nasopharyngeal Carcinoma - Episode 10

Clinical Scenario: Locally Recurrent NPC

, ,

Shravan Kandula, MD, presents the case of a patient with locally recurrent nasopharyngeal carcinoma.

EP. 1: Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach
EP. 2: Current Guidelines for Managing Nasopharyngeal Carcinoma
EP. 3: Overview of the JUPITER and POLARIS-2 Trials
EP. 4: Value of PD-L1 Biomarker in NPC
EP. 5: Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab
EP. 6: Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
EP. 7: Strategies to Mitigate Adverse Events in Nasopharyngeal Carcinoma Treatment
EP. 8: Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
EP. 9: Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects
Now Viewing
EP. 10: Clinical Scenario: Locally Recurrent NPC

Related Content:

Clinical Advances in Nasopharyngeal CarcinomaYale Cancer CenterCity of HopeHead & Neck CancersInsightsVideo Series
Dr Amanam on the Optimal Use of JAK Inhibitors in the Current Myelofibrosis Treatment Paradigm
Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects
Neoadjuvant Chemotherapy Could Enhance Organ Preservation in Nasal and Paranasal Sinus Squamous Cell Carcinoma